Overexpression of Protein Kinase C iota as a prognostic marker and its role in oxaliplatin resistance in colorectal cancer

Abstract Background Protein Kinase C iota (PKCι) has been implicated in cancer progression and chemoresistance, but its prognostic significance in solid tumors remains unclear. This study aimed to evaluate the expression of PKCι in tumor tissues and its association with clinicopathological features,...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuankai Liao, Mengyuan Liu, Chunli Hong, Yuyan Liu, Qing Li, Ying Chen, Tingzhen Zhang, Hongda Chen, Shuying Fu
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-025-04153-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849234745453445120
author Xuankai Liao
Mengyuan Liu
Chunli Hong
Yuyan Liu
Qing Li
Ying Chen
Tingzhen Zhang
Hongda Chen
Shuying Fu
author_facet Xuankai Liao
Mengyuan Liu
Chunli Hong
Yuyan Liu
Qing Li
Ying Chen
Tingzhen Zhang
Hongda Chen
Shuying Fu
author_sort Xuankai Liao
collection DOAJ
description Abstract Background Protein Kinase C iota (PKCι) has been implicated in cancer progression and chemoresistance, but its prognostic significance in solid tumors remains unclear. This study aimed to evaluate the expression of PKCι in tumor tissues and its association with clinicopathological features, survival outcomes, and chemotherapy response in patients with cancer. Methods A retrospective analysis was conducted on patients with confirmed cancer diagnoses. Immunohistochemistry (IHC) was used to assess PKCι expression levels in tumor tissues. Kaplan-Meier survival curves and univariate Cox analysis were applied to evaluate the impact of PKCι expression and other clinicopathological variables on overall survival (OS) and progression-free survival (PFS). The association between PKCι expression and chemotherapy resistance, particularly oxaliplatin resistance, was also investigated. Results PKCι overexpression was possibly correlated with advanced clinical stage, metastasis, organs involvement, vascular invasion, and perineural invasion. Patients with PKCι overexpression was possibly correlated with oxaliplatin resistance(P = 0.014). Besides, Patients with PKCι overexpression exhibited significantly shorter PFS compared to those with low expression levels (P = 0.0006). Univariate Cox analysis confirmed that metastasis (H.R. = 11.910, P = 0.018) and clinical staging (H.R. = 5.498, P = 0.027) were independent prognostic factors for OS, whereas CEA levels (H.R. = 3.497, P = 0.005) was independent predictors of PFS. Conclusion PKCι overexpression is associated with tumor aggressiveness and chemotherapy resistance, indicating its potential as a prognostic biomarker and therapeutic target in cancer preliminarily.
format Article
id doaj-art-0c874415f8f04448b914c162fb12aaa3
institution Kabale University
issn 1471-230X
language English
publishDate 2025-08-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj-art-0c874415f8f04448b914c162fb12aaa32025-08-20T04:03:02ZengBMCBMC Gastroenterology1471-230X2025-08-0125111110.1186/s12876-025-04153-xOverexpression of Protein Kinase C iota as a prognostic marker and its role in oxaliplatin resistance in colorectal cancerXuankai Liao0Mengyuan Liu1Chunli Hong2Yuyan Liu3Qing Li4Ying Chen5Tingzhen Zhang6Hongda Chen7Shuying Fu8Department of Pathology, The Seventh Affiliated Hospital, Sun Yat-sen UniversityDepartment of dermatology, The Seventh Affiliated Hospital, Sun Yat-sen UniversityDepartment of dermatology, The Seventh Affiliated Hospital, Sun Yat-sen UniversityDepartment of dermatology, The Seventh Affiliated Hospital, Sun Yat-sen UniversityDepartment of dermatology, The Seventh Affiliated Hospital, Sun Yat-sen UniversityDepartment of Traditional Chinese Medicine, Shenzhen Longhua Maternity and Child Healthcare HospitalDepartment of Pathology, The Seventh Affiliated Hospital, Sun Yat-sen UniversityDepartment of Traditional Chinese Medicine, The Seventh Affiliated Hospital, Sun Yat-sen UniversityDepartment of dermatology, The Seventh Affiliated Hospital, Sun Yat-sen UniversityAbstract Background Protein Kinase C iota (PKCι) has been implicated in cancer progression and chemoresistance, but its prognostic significance in solid tumors remains unclear. This study aimed to evaluate the expression of PKCι in tumor tissues and its association with clinicopathological features, survival outcomes, and chemotherapy response in patients with cancer. Methods A retrospective analysis was conducted on patients with confirmed cancer diagnoses. Immunohistochemistry (IHC) was used to assess PKCι expression levels in tumor tissues. Kaplan-Meier survival curves and univariate Cox analysis were applied to evaluate the impact of PKCι expression and other clinicopathological variables on overall survival (OS) and progression-free survival (PFS). The association between PKCι expression and chemotherapy resistance, particularly oxaliplatin resistance, was also investigated. Results PKCι overexpression was possibly correlated with advanced clinical stage, metastasis, organs involvement, vascular invasion, and perineural invasion. Patients with PKCι overexpression was possibly correlated with oxaliplatin resistance(P = 0.014). Besides, Patients with PKCι overexpression exhibited significantly shorter PFS compared to those with low expression levels (P = 0.0006). Univariate Cox analysis confirmed that metastasis (H.R. = 11.910, P = 0.018) and clinical staging (H.R. = 5.498, P = 0.027) were independent prognostic factors for OS, whereas CEA levels (H.R. = 3.497, P = 0.005) was independent predictors of PFS. Conclusion PKCι overexpression is associated with tumor aggressiveness and chemotherapy resistance, indicating its potential as a prognostic biomarker and therapeutic target in cancer preliminarily.https://doi.org/10.1186/s12876-025-04153-xPKCιCancer prognosisMetastasisVascular invasionOxaliplatin resistanceOverall survival
spellingShingle Xuankai Liao
Mengyuan Liu
Chunli Hong
Yuyan Liu
Qing Li
Ying Chen
Tingzhen Zhang
Hongda Chen
Shuying Fu
Overexpression of Protein Kinase C iota as a prognostic marker and its role in oxaliplatin resistance in colorectal cancer
BMC Gastroenterology
PKCι
Cancer prognosis
Metastasis
Vascular invasion
Oxaliplatin resistance
Overall survival
title Overexpression of Protein Kinase C iota as a prognostic marker and its role in oxaliplatin resistance in colorectal cancer
title_full Overexpression of Protein Kinase C iota as a prognostic marker and its role in oxaliplatin resistance in colorectal cancer
title_fullStr Overexpression of Protein Kinase C iota as a prognostic marker and its role in oxaliplatin resistance in colorectal cancer
title_full_unstemmed Overexpression of Protein Kinase C iota as a prognostic marker and its role in oxaliplatin resistance in colorectal cancer
title_short Overexpression of Protein Kinase C iota as a prognostic marker and its role in oxaliplatin resistance in colorectal cancer
title_sort overexpression of protein kinase c iota as a prognostic marker and its role in oxaliplatin resistance in colorectal cancer
topic PKCι
Cancer prognosis
Metastasis
Vascular invasion
Oxaliplatin resistance
Overall survival
url https://doi.org/10.1186/s12876-025-04153-x
work_keys_str_mv AT xuankailiao overexpressionofproteinkinaseciotaasaprognosticmarkeranditsroleinoxaliplatinresistanceincolorectalcancer
AT mengyuanliu overexpressionofproteinkinaseciotaasaprognosticmarkeranditsroleinoxaliplatinresistanceincolorectalcancer
AT chunlihong overexpressionofproteinkinaseciotaasaprognosticmarkeranditsroleinoxaliplatinresistanceincolorectalcancer
AT yuyanliu overexpressionofproteinkinaseciotaasaprognosticmarkeranditsroleinoxaliplatinresistanceincolorectalcancer
AT qingli overexpressionofproteinkinaseciotaasaprognosticmarkeranditsroleinoxaliplatinresistanceincolorectalcancer
AT yingchen overexpressionofproteinkinaseciotaasaprognosticmarkeranditsroleinoxaliplatinresistanceincolorectalcancer
AT tingzhenzhang overexpressionofproteinkinaseciotaasaprognosticmarkeranditsroleinoxaliplatinresistanceincolorectalcancer
AT hongdachen overexpressionofproteinkinaseciotaasaprognosticmarkeranditsroleinoxaliplatinresistanceincolorectalcancer
AT shuyingfu overexpressionofproteinkinaseciotaasaprognosticmarkeranditsroleinoxaliplatinresistanceincolorectalcancer